Myocardial infarction: ACE inhibitors for all? for ever?
- 30 July 1994
- journal article
- Published by Elsevier in The Lancet
- Vol. 344 (8918) , 279-281
- https://doi.org/10.1016/s0140-6736(94)91333-1
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial InfarctionNew England Journal of Medicine, 1992
- Effects of the Early Administration of Enalapril on Mortality in Patients with Acute Myocardial InfarctionNew England Journal of Medicine, 1992
- Fourth international study of infarct survival: Protocol for a large simple study of the effects of oral mononitrate, of oral captopril, and of intravenous magnesiumThe American Journal of Cardiology, 1991
- Enalaprilat in acute myocardial infarction: tolerability and effects on the renin-angiotensin systemInternational Journal of Cardiology, 1991
- Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart FailureNew England Journal of Medicine, 1991
- Delayed but not immediate captopril therapy improves cardiac function in conscious rats, following myocardial infarctionJournal of Molecular and Cellular Cardiology, 1991
- Long-term benefit of early thrombolytic therapy in patients with acute myocardial infarction: 5 year follow-up of a trial conducted by the Interuniversity Cardiology Institute of the NetherlandsJournal of the American College of Cardiology, 1989
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987
- Concentration-Dependent Protection by Captopril Against Myocardial Damage During Ischemia and Reperfusion in a Closed Chest Pig ModelJournal of Cardiovascular Pharmacology, 1987
- Preservation of ischemic myocardium by a new converting enzyme inhibitor, enalaprilic acid, in acute myocardial infarctionAmerican Heart Journal, 1985